A peer-reviewed study published last month found the prophylactic use of ivermectin reduced COVID mortality by 90% among more than 223,000 study participants in a town in Southern Brazil.
The study, published in the Cureus Journal of Medical Science, also found a 44% reduction in COVID cases among those who took the re-purposed drug.
Between July 7, 2020, and Dec. 2, 2020, all residents of Itajaí were offeredivermectin. Approximately 3.7% of ivermectin users contracted COVID during the trial period, compared with 6.6% of residents who didn’t take the drug.
Based on the results, Dr…
View original post 302 more words